VACCINES TO FIGHT NEW VARIANTS SHOULD BE AVAILABLE BY THIRD QUARTER, SAYS SHABIR MADHI, LEAD INVESTIGATOR FOR OXFORD/ASTRAZENECA VACCINE TRIAL IN SOUTH AFRICA

PUBLISHED: Tue, 09 Feb 2021 17:59:40 GMT
Share

VACCINES TO FIGHT NEW VARIANTS SHOULD BE AVAILABLE BY THIRD QUARTER, SAYS SHABIR MADHI, LEAD INVESTIGATOR FOR OXFORD/ASTRAZENECA VACCINE TRIAL IN SOUTH AFRICA

Sign Up for Our Newsletter Daily Update

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html